Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria

J Microbiol Methods. 2012 Sep;90(3):160-6. doi: 10.1016/j.mimet.2012.05.001. Epub 2012 May 27.

Abstract

The minimum inhibitory concentrations (MICs) obtained from the susceptibility testing of various bacteria to antibiotics were determined by a colorimetric microbial viability assay based on reduction of a tetrazolium salt {2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8)} via 2-methyl-1,4-napthoquinone as an electron mediator and compared with those obtained by the broth microdilution methods approved by the Clinical and Laboratory Standard Institute (CLSI). Especially for drug-resistant bacteria, the CLSI method at an incubation time of 24h tended to give lower MICs. The extension of incubation time was necessary to obtain consistent MICs for drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococi (VRE) and multi-drug resistant Pseudomonas aeruginosa (MDRP) in the broth microdilution method. There was excellent agreement between the MICs determined after 24h using the WST-8 colorimetric method and those obtained after 48-96 h using the broth microdilution method. The results suggest that the WST-8 colorimetric assay is a useful method for rapid determination of consistent MICs for drug-resistant bacteria.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology
  • Colorimetry
  • Culture Media
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / growth & development
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / growth & development
  • Indicator Dilution Techniques
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / growth & development
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Microbial Sensitivity Tests / methods*
  • Microbial Viability / drug effects
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / growth & development
  • Vancomycin / pharmacology
  • Vancomycin Resistance*
  • beta-Lactam Resistance*
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • Culture Media
  • beta-Lactams
  • Ciprofloxacin
  • Vancomycin